These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 2767790
21. Impact of recombinant erythropoietin on sexual function in hemodialysis patients. Schaefer RM, Kokot F, Heidland A. Contrib Nephrol; 1989; 76():273-81; discussion 281-2. PubMed ID: 2684527 [No Abstract] [Full Text] [Related]
22. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis]. Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G. Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107 [Abstract] [Full Text] [Related]
23. Hemodynamics of patients with renal failure treated with recombinant human erythropoietin. Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH. Clin Nephrol; 1989 Jan; 31(1):6-11. PubMed ID: 2914412 [Abstract] [Full Text] [Related]
24. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients. Delano BG. Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025 [Abstract] [Full Text] [Related]
25. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients. Mohini R. Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516 [Abstract] [Full Text] [Related]
26. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis. Li WY, Chu TS, Huang JW, Wu MS, Wu KD. J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153 [Abstract] [Full Text] [Related]
27. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Nissenson AR. Semin Nephrol; 1989 Mar; 9(1 Suppl 2):25-31. PubMed ID: 2669083 [Abstract] [Full Text] [Related]
28. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu O, Feldman J, Friedman EA. N Engl J Med; 1996 Feb 15; 334(7):420-5. PubMed ID: 8552143 [Abstract] [Full Text] [Related]
29. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO). Roger SD, Baker LR, Raine AE. Clin Nephrol; 1993 Feb 15; 39(2):103-10. PubMed ID: 8448912 [Abstract] [Full Text] [Related]
30. [Effect of low-dose recombinant humane erythropoietin therapy on the quality of life in patients with anemia in the course of end-stage renal failure treated with dialysis]. Matuszkiewicz-Rowińska J, Marusza W, Andrzejewski A, Goliat E, Pacocha E, Switalski M, Zawadzka M, Ostrowski K. Pol Arch Med Wewn; 1996 Aug 15; 96(2):143-52. PubMed ID: 9122002 [Abstract] [Full Text] [Related]
31. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan. Akizawa T, Koshikawa S, Takaku F, Urabe A, Akiyama N, Mimura N, Otsubo O, Nihei H, Suzuki Y, Kawaguchi Y. Int J Artif Organs; 1988 Sep 15; 11(5):343-50. PubMed ID: 3056862 [Abstract] [Full Text] [Related]
32. Practical considerations of recombinant human erythropoietin therapy. Paganini EP, Latham D, Abdulhadi M. Am J Kidney Dis; 1989 Aug 15; 14(2 Suppl 1):19-25. PubMed ID: 2667348 [Abstract] [Full Text] [Related]
33. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin]. Sivak L, Scuteri RM, Cavalli NH, Gotlieb D, López Blanco OA. Medicina (B Aires); 1992 Aug 15; 52(6):516-22. PubMed ID: 1340900 [Abstract] [Full Text] [Related]
34. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin]. Prata MM, de Sousa FT, Barbas JV, da Costa AM, Vinhas J, Moreira P, Abrantes C, Lopes MC. Acta Med Port; 1990 Aug 15; 3(3):149-53. PubMed ID: 2220424 [Abstract] [Full Text] [Related]
35. Erythrocyte vitamins B1, B2 and B6 and erythropoietin. Mydlik M, Derzsiová K. Am J Nephrol; 1993 Aug 15; 13(6):464-6. PubMed ID: 8141181 [Abstract] [Full Text] [Related]
36. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T. Ther Apher Dial; 2010 Jun 15; 14(3):240-75. PubMed ID: 20609178 [Abstract] [Full Text] [Related]
37. Effects of recombinant human erythropoietin on the plasma levels of vasoactive regulatory peptides in patients on maintenance hemodialysis. Hegbrant J, Thysell H, Ekman R. Int J Artif Organs; 1991 Jul 15; 14(7):411-6. PubMed ID: 1889894 [Abstract] [Full Text] [Related]
38. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662 [Abstract] [Full Text] [Related]
39. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management. Van Wyck DB. Semin Nephrol; 1989 Mar 13; 9(1 Suppl 2):21-4. PubMed ID: 2669082 [Abstract] [Full Text] [Related]
40. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency]. Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F. Sangre (Barc); 1990 Feb 13; 35(1):82-4. PubMed ID: 2333585 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]